Company Badge
USPTO Data Jan 1 1976 - Oct 27 2026
8 Patents
#56 in Lund
#720 in Sweden
Hansa Biopharma Ab
Forward Citations = 21
11 inventors:
Hansa Biopharma Ab
Calculating rank
EPO Patents = 5
Trademarks = 5
Forward Citations = 21
Loading Chart...
Loading Chart...
11 inventors (with patents filed for the assignee):
Christian Kjellman (8 out of 9 patents)
Sofia Jarnum (7 out of 8 patents)
Emma Nordahl (7 out of 7 patents)
4. Lena Winstedt (1 out of 2 patents)
5. Kaisa Karhumaa (1 out of 2 patents)
6. Sofia Järnum (1 out of 1 patent)
7. Robert Bockermann (1 out of 1 patent)
8. Karl Markus Roupé (1 out of 1 patent)
9. Colin Charles Anderson (0 patent)
10. Jiaxin Lin (0 patent)
11. Anna-Karin Louise Robertson (0 patent)
8 patents:
Company Overview
Hansa Biopharma is a biopharmaceutical company focused on developing innovative immunomodulatory enzyme technology to address unmet medical needs. Their lead product, Idefirix, is approved for the prevention of kidney transplant rejection in highly sensitized patients.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Hansa Biopharma Ab. Retrieved from https://idiyas.com/company/hansa-biopharma-ab
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
5 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]